This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GE Healthcare Announces FDA Approval To Supply Technetium 99m Generators

Effective from June 1 st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc 99m) injection to its radiopharmacies in the US.

Globally more than 70 percent of all diagnostic SPECT (single photon emission computed tomography) procedures using gamma cameras rely on the use of Tc 99m as the radioactive component. It is commonly used as an imaging agent and in preparation of FDA-approved diagnostic radiopharmaceutical kits to help diagnose many different types of diseases including those in cardiology, oncology, and neurology.

GE Healthcare is responsible for more than 30 percent of the world’s supply of radioactive tracers and has 31 radiopharmacies in the US.

“Radioactive tracers are difficult to manufacture because of their short half-life. By supplying our generators, GE Healthcare has better control over its supply chain. It could also help to increase the availability of Tc 99m for our customers in the longer term,“ said Jan Makela, GM, Core Imaging. “Currently we supply Tc 99m generators (branded Drytec™ outside the US) to many countries around the world and the inclusion of the US is a big step to increasing our leadership in this market. It represents a significant growth opportunity for our SPECT business.”

Technetium-99m, when used as a radioactive tracer , can be detected in the body by medical equipment such as gamma cameras. The short physical half-life, or time it remains radioactive, of the isotope and its biological half-life of 1 day (in terms of human activity and metabolism) allows for scanning procedures which collect data rapidly but keep total patient radiation exposure low.

Important Risk and Safety Information for Sodium Pertechnetate Tc99m Injection

Long term cumulative radiation exposure is associated with increased risk of cancer. Radiation risks associated with the use of sodium pertechnetate Tc99m injection are greater in children than in adults. In general, the younger the child, the greater the risk owing to greater absorbed radiation doses and longer life expectancy. These greater risks should be taken firmly into account in all benefit-risk assessments involving children.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.02 0.00%
FB $104.07 0.00%
GOOG $683.57 0.00%
TSLA $162.60 0.00%
YHOO $27.97 0.00%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs